Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

150 ARTÍCULOS , VIENDO DEL 136 AL 150

In Vivo Comparison of Tau Radioligands (18)F-THK-5351 and (18)F-THK-5317

Betthauser TJ, Lao PJ, Murali D, Barnhart TE, Furumoto S, Okamura N, Stone CK, Johnson SC, Christian BT.

J Nucl Med. 2017 Jun;58(6):996-1002. doi: 10.2967/jnumed.116.182980. Epub 2016 Nov 10.

[Alzheimer's disease cerebro-spinal fluid biomarkers: A clinical research tool sometimes useful in daily clinical practice of memory clinics for the diagnosis of complex cases]

Magnin E, Dumurgier J, Bouaziz-Amar E, Bombois S, Wallon D, Gabelle A, Lehmann S, Blanc F, Bousiges O, Hannequin D, Jung B, Miguet-Alfonsi C, Quillard M, Pasquier F, Peoc'h K, Laplanche JL, Hugon J, Paquet C; pour le groupe ePLM (étude des biomarqueurs de la Ponction Lombaire Multicentrique).

Rev Med Interne. 2017 Apr;38(4):250-255. doi: 10.1016/j.revmed.2016.10.383. Epub 2016 Nov 24.

Kinetic Modeling of the Tau PET Tracer (18)F-AV-1451 in Human Healthy Volunteers and Alzheimer Disease Subjects

Barret O, Alagille D, Sanabria S, Comley RA, Weimer RM, Borroni E, Mintun M, Seneca N, Papin C, Morley T, Marek K, Seibyl JP, Tamagnan GD, Jennings D.

J Nucl Med. 2017 Jul;58(7):1124-1131. doi: 10.2967/jnumed.116.182881. Epub 2016 Dec 1.

The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement

Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR Jr, Jagust W, Morris JC, Petersen RC, Salazar J, Saykin AJ, Shaw LM, Toga AW, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2017 May;13(5):561-571. doi: 10.1016/j.jalz.2016.10.006. Epub 2016 Dec 5.

Non human primate models for Alzheimer's disease-related research and drug discovery

Van Dam D, De Deyn PP.

Expert Opin Drug Discov. 2017 Feb;12(2):187-200. doi: 10.1080/17460441.2017.1271320. Epub 2016 Dec 25.

Comparison of cerebrospinal fluid profiles in Alzheimer's disease with multiple cerebral microbleeds and cerebral amyloid angiopathy-related inflammation

Kimura A, Takemura M, Saito K, Yoshikura N, Hayashi Y, Harada N, Nishida H, Nakajima H, Inuzuka T.

J Neurol. 2017 Feb;264(2):373-381. doi: 10.1007/s00415-016-8362-2. Epub 2016 Dec 20.

Transcriptional and epigenetic phenomena in peripheral blood cells of monozygotic twins discordant for alzheimer's disease, a case report

D'Addario C, Candia SB, Arosio B, Di Bartolomeo M, Abbate C, Casè A, Candeletti S, Romualdi P, Damanti S, Maccarrone M, Bergamaschini L, Mari D.

J Neurol Sci. 2017 Jan 15;372:211-216. doi: 10.1016/j.jns.2016.11.052. Epub 2016 Nov 24.

Emerging ocular biomarkers of Alzheimer disease

van Wijngaarden P, Hadoux X, Alwan M, Keel S, Dirani M.

Clin Exp Ophthalmol. 2017 Jan;45(1):54-61. doi: 10.1111/ceo.12872. Epub 2016 Dec 19.

Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia

Simonsen AH, Herukka SK, Andreasen N, Baldeiras I, Bjerke M, Blennow K, Engelborghs S, Frisoni GB, Gabryelewicz T, Galluzzi S, Handels R, Kramberger MG, Kulczyńska A, Molinuevo JL, Mroczko B, Nordberg A, Oliveira CR, Otto M, Rinne JO, Rot U, Saka E, Soininen H, Struyfs H, Suardi S, Visser PJ, Winblad B, Zetterberg H, Waldemar G.

Alzheimers Dement. 2017 Mar;13(3):274-284. doi: 10.1016/j.jalz.2016.09.008. Epub 2016 Oct 27.

Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment

Herukka SK, Simonsen AH, Andreasen N, Baldeiras I, Bjerke M, Blennow K, Engelborghs S, Frisoni GB, Gabryelewicz T, Galluzzi S, Handels R, Kramberger MG, Kulczyńska A, Molinuevo JL, Mroczko B, Nordberg A, Oliveira CR, Otto M, Rinne JO, Rot U, Saka E, Soininen H, Struyfs H, Suardi S, Visser PJ, Winblad B, Zetterberg H, Waldemar G.

Alzheimers Dement. 2017 Mar;13(3):285-295. doi: 10.1016/j.jalz.2016.09.009. Epub 2016 Oct 27.

Understanding Epigenetic Alterations in Alzheimer's and Parkinson's Disease: Towards Targeted Biomarkers and Therapies

Ciceri F, Rotllant D, Maes T.

Curr Pharm Des. 2017;23(5):839-857. doi: 10.2174/1381612823666170124121140.

In vivo ROS production and use of oxidative stress-derived biomarkers to detect the onset of diseases such as Alzheimer's disease, Parkinson's disease, and diabetes

Umeno A, Biju V, Yoshida Y.

Free Radic Res. 2017 Apr;51(4):413-427. doi: 10.1080/10715762.2017.1315114. Epub 2017 Apr 25.

Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer's disease and Parkinson's disease: Mendelian randomisation study

Benn M, Nordestgaard BG, Frikke-Schmidt R, Tybjærg-Hansen A.

BMJ. 2017 Apr 24;357:j1648. doi: 10.1136/bmj.j1648.

Gene networks in neurodegenerative disorders

Recabarren D, Alarcón M.

Life Sci. 2017 Aug 15;183:83-97. doi: 10.1016/j.lfs.2017.06.009. Epub 2017 Jun 13.

Similarity and Differences in Inflammation-Related Characteristics of the Peripheral Immune System of Patients with Parkinson's and Alzheimer's Diseases

Boyko AA, Troyanova NI, Kovalenko EI, Sapozhnikov AM.

Int J Mol Sci. 2017 Dec 6;18(12):2633. doi: 10.3390/ijms18122633.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias